In STEMI patients undergoing early revascularization, LVEF < 40% was a strong independent predictor of in-hospital mortality (OR 5.72; 95% CI 2.77-11.80; p<0.001).
Cohort (n=512)
In STEMI patients undergoing early revascularization, LVEF < 40%, ischemic mitral regurgitation, anemia, and renal impairment strongly predict in-hospital mortality.
Effect estimate: OR 5.72 (95% CI 2.77-11.80)
p-value: p=<0.001
Background: Despite advances in reperfusion therapy, ST-segment elevation myocardial infarction (STEMI) remains associated with substantial morbidity and mortality. Early identification of predictors of adverse outcomes is essential for improving risk stratification. Methods: This retrospective study included 512 STEMI patients who underwent coronary revascularization within 6 h of symptom onset. Clinical, laboratory, angiographic and echocardiographic variables were analyzed. The primary endpoint was in-hospital mortality. Secondary outcomes included reduced left ventricular ejection fraction (LVEF < 40%) and moderate-to-severe ischemic mitral regurgitation (IMR). Independent predictors of in-hospital mortality were identified using multivariable logistic regression, while secondary outcomes were described to characterize the study population. Model performance was evaluated using ROC analysis. Results: In-hospital mortality occurred in 9.4% of patients. Reduced LVEF was present in 26.2%, and IMR in 10.9%. Independent predictors of mortality included LVEF < 40% (OR 5.72, 95% CI 2.77–11.80, p < 0.001), IMR (OR 2.61, 95% CI 1.14–5.97, p = 0.023), lower hemoglobin levels (OR 0.74, 95% CI 0.61–0.91, p = 0.003), and reduced glomerular filtration rate (OR 0.96, 95% CI 0.95–0.98, p < 0.001). The model demonstrated good discrimination (AUC 0.88). Complete revascularization was not independently associated with mortality. Conclusions: Left ventricular dysfunction, IMR, anemia, and renal impairment are strong predictors of in-hospital mortality in STEMI patients. Integrating echocardiographic and laboratory parameters may improve early risk stratification and guide clinical decision-making.
Cinezan et al. (Fri,) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=512). In STEMI patients undergoing early revascularization, LVEF < 40% was a strong independent predictor of in-hospital mortality (OR 5.72; 95% CI 2.77-11.80; p<0.001).